SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001607062-16-000813
Filing Date
2016-04-29
Accepted
2016-04-28 19:49:37
Documents
57
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q rgbp033116form10q.htm 10-Q 353737
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 49832
3 EXHIBIT 31.1 ex31_1.htm EX-31.1 8152
4 EXHIBIT 31.2 ex31_2.htm EX-31.2 7874
5 EXHIBIT 32.1 ex32_1.htm EX-32.1 4609
6 EXHIBIT 32.2 ex32_2.htm EX-32.2 4455
  Complete submission text file 0001607062-16-000813.txt   1944497

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE rgbp-20151231.xml EX-101.INS 211577
8 XBRL SCHEMA FILE rgbp-20151231.xsd EX-101.SCH 29727
9 XBRL CALCULATION FILE rgbp-20151231_cal.xml EX-101.CAL 32878
10 XBRL DEFINITION FILE rgbp-20151231_def.xml EX-101.DEF 68938
11 XBRL LABEL FILE rgbp-20151231_lab.xml EX-101.LAB 156439
12 XBRL PRESENTATION FILE rgbp-20151231_pre.xml EX-101.PRE 145169
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-702-1404
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

IRS No.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 333-191725 | Film No.: 161602025
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences